Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
Superinvestors holding EWTX, Q2 2026
No superinvestor reported holding EWTX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of EWTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−60.0%)
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−17.3%)
Q2 2024
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−55.6%)
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−45.8%)
Q3 2023
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+3.6%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+21.1%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+11.3%)
Q3 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+61.7%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−18.6%)